Cargando…
Transjugular intrahepatic portosystemic shunt in patients with hepatocellular carcinoma: A systematic review
BACKGROUND/AIMS: Transjugular intrahepatic portosystemic shunts (TIPS) in patients with hepatocellular carcinoma (HCC) may improve access to curative therapies, treat portal hypertension (PH)‐related complications without worsening liver function, and increase overall survival. Data on the efficacy...
Autores principales: | Norero, Blanca, Bosch, Jaume, Berzigotti, Annalisa, Rodrigues, Susana G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576600/ https://www.ncbi.nlm.nih.gov/pubmed/37736854 http://dx.doi.org/10.1002/ueg2.12454 |
Ejemplares similares
-
Salvage transjugular intrahepatic portosystemic shunt in patients with cirrhosis and refractory variceal bleeding: A systematic review with meta‐analysis
por: Weichselbaum, Laura, et al.
Publicado: (2022) -
Diastolic dysfunction is associated with cardiac decompensation after transjugular intrahepatic portosystemic shunt in patients with liver cirrhosis
por: Schneider, Hannah, et al.
Publicado: (2023) -
The Evolution of Transjugular Intrahepatic Portosystemic Shunt: Tips
por: Fanelli, Fabrizio
Publicado: (2014) -
Parallel Shunt for the Treatment of Transjugular Intrahepatic Portosystemic Shunt Dysfunction
por: Luo, Xuefeng, et al.
Publicado: (2013) -
The effects of a transjugular intrahepatic portosystemic shunt on the diagnosis of hepatocellular cancer
por: Wong, Katherine, et al.
Publicado: (2018)